Main completed research projects on Halotherapy

1. A series of experiments to study the physical properties of air-dispersing systems were done. In particular, research on the dynamics of the distribution of dry salt aerosol in rooms. Major factors affecting the lifetime of the dry salt aerosol were identified. The specific features of generation and distribution of the respirable fraction of dry salt aerosol in limited quantities were assessed. The electrical characteristics of various aerosol environments were tested. The dependence of dynamics of the dry salt aerosol on temperature and moisture characteristics of the environment was discovered. These and other experiments and research laid down the basis for the development of the behavioral algorithm of the salt aerosol inside the rooms and the developing of a new generation of technical tools for the realization of the Controlled Halotherapy.
Jointly with The St. Petersburg State Medical University named after Acad. I. Pavlov and The St. Petersburg State University of Aerospace Instrumentation.

2. The mechanisms for the therapeutic and preemptive impact of the Controlled Halotherapy were defined regarding a comprehensive assessment of the effect of sodium chloride dry fine aerosol on defense mechanisms in the respiratory tract. The clinical and pathogenic rationale of the influence of sodium chloride aerosol dry fine on bronchial patency was produced.
Jointly with St. Petersburg State Medical University named after Acad. I. Pavlov, Institute of Pulmonology, FMBA of Russia (Moscow), Institute of Childhood Infections, FMBA of Russia, Clinical Hospital № 122 named after L. Sokolov, FMBA of Russia.

3. The impact of sodium chloride dry fine aerosol on the properties of microorganisms and physiological properties of the epithelium in the experiment was examined.
Jointly with the Institute for Childhood Infections, FMBA of Russia, Clinical Hospital № 122 named after L. Sokolov, FMBA of Russia.

4. A differential approach and methodological basis for the prescription of various concentrations of sodium chloride dry salt aerosol, depending on clinical and functional parameters were developed. Recommendations and contraindications, some particulars for the application of the method application for rehabilitation and prevention purposes were elaborated.
Jointly with St. Petersburg State Medical University named after Acad. I. Pavlov, Institute of Pulmonology, FMBA of Russia (Moscow), Clinical Hospital № 122 named after L. Sokolov, FMBA of Russia, Military Medical Academy named after S. Kirov.

5. Clinical efficiency of the method with the use of placebo-control for the patients with major forms of acute and chronic bronchopulmonary system was tested. The data on the effectiveness of the Controlled Halotherapy in the overall treatment of patients with bronchial asthma, COPD, who receive essential medical therapy under the requirements of the modern international regulations, were received. The effect of the developed method with the patients with bronchial asthma was studied, regarding pathogenic variant and severity. The possibility of applying the Controlled Halotherapy for the patients with cystic fibrosis was assessed.
Jointly with St. Petersburg State Medical University named after Acad. I. Pavlov, Institute of Pulmonology, FMBA of Russia (Moscow), Clinical Hospital № 122 named after L. Sokolov, FMBA of Russia, Military Medical Academy named after S. Kirov.

6. Based on a comprehensive clinical testing and in-depth study of epidemiological indicators a preventive effect of the Controlled Halotherapy was proved.
Jointly with the Clinical Hospital № 122 named after L. Sokolov, FMBA of Russia, Institute of Childhood Infections, FMBA of Russia, the Russian Scientific Center for Restorative Medicine and Balneology of Studies, Proctor & Gambles’ European and East European Directorate for Science (USA).

7. The impact mechanisms and clinical efficiency of the Controlled Halotherapy for the pathology of the upper respiratory tract were examined. The modes of dry salt aerosol concentration were developed.
Jointly with St. Petersburg State Medical University named after Acad. I. Pavlov, Institute of Pulmonology, FMBA of Russia (Moscow), Institute of Childhood Infections, FMBA of Russia, Clinical Hospital № 122 named after L. Sokolov, FMBA of Russia.

8. Clinical efficiency was examined, and some recommendations and contraindications were produced for the application of the Controlled Halotherapy in pediatric practice. The prescription modes for dry salt aerosol concentrations, duration of treatment for various diseases for kids were developed.
Jointly with the Clinical Hospital № 122 named after L. Sokolov, FMBA of Russia, the Russian Scientific Center for Restorative Medicine and Balneology Studies, Scientific Center of Children’s Health, Russian Academy of Medical Sciences.

9. The efficiency of the Controlled Halotherapy in children’s pre-school and educational institutions was examined. The modes of dry salt aerosol concentrations and patterns of its use were developed.
Jointly with the Russian Scientific Center for Restorative Medicine and Balneology of HealthCare Authority of Russia.

10. The efficiency of the application of the Controlled Halotherapy for seniors and comorbidity was tested. The modes of dry salt aerosol concentrations and patterns of use of the method in overall treatment were developed.
Jointly with the National Institute of Advanced Medical of the Defense Ministry of Russia, Clinical Hospital № 122 named after L. Sokolov, FMBA of Russia, Scientific Centre of Cardiovascular Surgery named after A. Bakulev, RAMS.

11. The efficiency of the application of the Controlled Halotherapy for professional lung diseases was examined. The developed method was laid down the organization of preventive and recovery treatment for the patients with toxic-chemical bronchitis.
Jointly with the Clinical Hospital № 122 named after L. Sokolov, FMBA of Russia, Institute of Postgraduate Professional Education FMBTS named after A. Burnazyan, FMBA of Russia (Moscow).

12. The efficiency of the Controlled Halotherapy in rehabilitation therapy of patients with chronic obstructive pulmonary disease (COPD). Clinical, functional parameters and measures of health-related quality of life (HRQL) by SF-16 and LCQ (10 items) were estimated after rehabilitation therapy procedures and in 3 months. Application of Halotherapy, using dry sodium chloride aerosol, on the background of the rehabilitation therapy in patients with COPD rendered to positive effect.
Jointly with Dep. of Balneology and Physical Medicine Collegium Medicum in Bydgoszcz, UMK (Poland).

Halomed halogenerators at favorable prices

Institute of Respiratory Hygiene and Halotherapy Kft. is a scientific-medical division of the Halomed-Aeromed Group and a Worldwide export partner of Halomed UAB.

www.irhh.net · www.haloset.eu · www.halocare.info

Facebook profile - Professional solutions for Halotherapy (@halotherapy.pro)  Instagram profile - Controlled Halotherapy (@halotherapy_pro)

© 2019 Institute of Respiratory Hygiene and Halotherapy Kft.
© 2019 Prof. Alina V. Chervinskaya, M.D., Ph.D.
All rights reserved.